350 related articles for article (PubMed ID: 32927376)
1. COVID-19 in systemic lupus erythematosus: Data from a survey on 417 patients.
Ramirez GA; Gerosa M; Beretta L; Bellocchi C; Argolini LM; Moroni L; Della Torre E; Artusi C; Nicolosi S; Caporali R; Bozzolo EP; Dagna L;
Semin Arthritis Rheum; 2020 Oct; 50(5):1150-1157. PubMed ID: 32927376
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 Infection and COVID-19 in 5 Patients in Ecuador After Prior Treatment with Hydroxychloroquine for Systemic Lupus Erythematosus.
Zurita MF; Iglesias Arreaga A; Luzuriaga Chavez AA; Zurita L
Am J Case Rep; 2020 Sep; 21():e927304. PubMed ID: 32978364
[TBL] [Abstract][Full Text] [Related]
3. Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review.
He F; Luo Q; Lei M; Fan L; Shao X; Hu K; Qin S; Yu N; Cao J; Yang L
Clin Rheumatol; 2020 Sep; 39(9):2803-2810. PubMed ID: 32725351
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine.
Bozzalla Cassione E; Zanframundo G; Biglia A; Codullo V; Montecucco C; Cavagna L
Ann Rheum Dis; 2020 Oct; 79(10):1382-1383. PubMed ID: 32398281
[No Abstract] [Full Text] [Related]
5. Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19.
Konig MF; Kim AH; Scheetz MH; Graef ER; Liew JW; Simard J; Machado PM; Gianfrancesco M; Yazdany J; Langguth D; Robinson PC;
Ann Rheum Dis; 2020 Oct; 79(10):1386-1388. PubMed ID: 32381561
[No Abstract] [Full Text] [Related]
6. Possible Consequences of a Shortage of Hydroxychloroquine for Patients with Systemic Lupus Erythematosus amid the COVID-19 Pandemic.
Peschken CA
J Rheumatol; 2020 Jun; 47(6):787-790. PubMed ID: 32269064
[No Abstract] [Full Text] [Related]
7. ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
McEniery CM; Fisk M; Miles K; Kaloyirou F; Hubsch A; Smith J; Wilkinson IB; Cheriyan J
Trials; 2020 Jul; 21(1):604. PubMed ID: 32616067
[TBL] [Abstract][Full Text] [Related]
8. Controversies over hydroxychloroquine in the prevention of SARS-CoV-2 infection put rheumatologists on the frontline.
Bugatti S; De Stefano L; Bobbio-Pallavicini F; Montecucco C
RMD Open; 2020 Oct; 6(3):. PubMed ID: 33087414
[No Abstract] [Full Text] [Related]
9. Impact of COVID-19 pandemic on SLE: beyond the risk of infection.
Horisberger A; Moi L; Ribi C; Comte D
Lupus Sci Med; 2020 May; 7(1):. PubMed ID: 32376774
[No Abstract] [Full Text] [Related]
10. COVID-19 in patients with systemic lupus erythematosus: A systematic review.
Fu XL; Qian Y; Jin XH; Yu HR; Du L; Wu H; Chen HL; Shi YQ
Lupus; 2022 May; 31(6):684-696. PubMed ID: 35382637
[TBL] [Abstract][Full Text] [Related]
11. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series.
Ferri C; Giuggioli D; Raimondo V; L'Andolina M; Tavoni A; Cecchetti R; Guiducci S; Ursini F; Caminiti M; Varcasia G; Gigliotti P; Pellegrini R; Olivo D; Colaci M; Murdaca G; Brittelli R; Mariano GP; Spinella A; Bellando-Randone S; Aiello V; Bilia S; Giannini D; Ferrari T; Caminiti R; Brusi V; Meliconi R; Fallahi P; Antonelli A;
Clin Rheumatol; 2020 Nov; 39(11):3195-3204. PubMed ID: 32852623
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 in Patients With Inflammatory Bowel Disease: A Single-center Observational Study in Northern Italy.
Viganò C; Massironi S; Pirola L; Cristoferi L; Fichera M; Bravo M; Mauri M; Redaelli AE; Dinelli ME; Invernizzi P
Inflamm Bowel Dis; 2020 Oct; 26(11):e138-e139. PubMed ID: 32949238
[No Abstract] [Full Text] [Related]
14. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
[TBL] [Abstract][Full Text] [Related]
15. Clinical management of Lupus patients during the COVID-19 pandemic.
Mason A; Rose E; Edwards CJ
Lupus; 2020 Nov; 29(13):1661-1672. PubMed ID: 33059530
[TBL] [Abstract][Full Text] [Related]
16. Flattening the curve in 52 days: characterisation of the COVID-19 pandemic in the Principality of Liechtenstein - an observational study.
Thiel SL; Weber MC; Risch L; Wohlwend N; Lung T; Hillmann D; Ritzler M; Risch M; Kohler P; Vernazza P; Kahlert CR; Fleisch F; Cusini A; Karajan TV; Copeland S; Paprotny M
Swiss Med Wkly; 2020 Oct; 150():w20361. PubMed ID: 33105020
[TBL] [Abstract][Full Text] [Related]
17. Can hydroxychloroquine protect patients with rheumatic diseases from COVID-19? Response to: 'Does hydroxychloroquine prevent the transmission of COVID-19?' by Heldwein and Calado and 'SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment' by Joob and Wiwanitkit.
Monti S; Montecucco C
Ann Rheum Dis; 2020 Jun; 79(6):e62. PubMed ID: 32327429
[No Abstract] [Full Text] [Related]
18. Novel coronavirus epidemic in the Hungarian population, a cross-sectional nationwide survey to support the exit policy in Hungary.
Merkely B; Szabó AJ; Kosztin A; Berényi E; Sebestyén A; Lengyel C; Merkely G; Karády J; Várkonyi I; Papp C; Miseta A; Betlehem J; Burián K; Csóka I; Vásárhelyi B; Ludwig E; Prinz G; Sinkó J; Hankó B; Varga P; Fülöp GÁ; Mag K; Vokó Z;
Geroscience; 2020 Aug; 42(4):1063-1074. PubMed ID: 32677025
[TBL] [Abstract][Full Text] [Related]
19. Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
González R; García-Otero L; Pons-Duran C; Marbán-Castro E; Goncé A; Llurba E; Gil MDM; Rodríguez-Zambrano MÁ; Chen H; Ramírez M; Bardají A; Menendez C
Trials; 2020 Jul; 21(1):607. PubMed ID: 32616063
[TBL] [Abstract][Full Text] [Related]
20. SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment.
Joob B; Wiwanitkit V
Ann Rheum Dis; 2020 Jun; 79(6):e61. PubMed ID: 32295787
[No Abstract] [Full Text] [Related]
[Next] [New Search]
